J Korean Med Sci.  2013 Jun;28(6):808-813. 10.3346/jkms.2013.28.6.808.

Disability Weights for Cancers in Korea

• Choi KS
• Park JH
• Lee KS

• KMID: 2158025
• DOI: http://doi.org/10.3346/jkms.2013.28.6.808

Abstract

This study renewed the estimation of disability weights for cancers in Korea, reflecting the nation's economic and medical-technological development during the past 10 yr. Thirty-two medical doctors evaluated disability weights for 24 major cancers based on the visual analogue scale (VAS) method. To check the intra-rater reliability, a correlation was calculated between 2011 and 2012 medians. To assess the inter-rater reliability, a correlation was estimated between oncologist and non-oncologist medians. To assess the inter-method reliability, a correlation was calculated between medians on VAS and Person-Trade-Off approaches. Moreover, findings in this study were compared to those in 2003 research. Spearman correlation was used and the 1% significance level was applied. Disability weights were relatively high for pancreas cancer (0.90), gallbladder cancer (0.81), mouth and oropharynx cancer (0.80), and esophagus cancer (0.80). Conversely, they were relatively low for breast cancer (0.37), prostate cancer (0.33) and thyroid cancer (0.10). All the inter-rater reliabilities were higher than 0.7. Indeed, the intra-rater and inter-method reliabilities were 0.752 and 0.927, respectively. Above all, disability weights for major cancers went down in Korea during 2003-2012, reflecting the progress of medical technology and the growth of cancer survival.

Keyword

Burden of Disease; Disability Weights; Neoplasms

MeSH Terms

Cost of Illness
*Disability Evaluation
Humans
Neoplasms/economics/*physiopathology
Republic of Korea

Reference

1. Korea Cancer Information Center. Cancer statistics: incidence rate. accessed on 8 October 2012. Available at http://www.cancer.go.kr/ncic/cics_f/01/011/index.html.

2. Jung KW, Park S, Kong HJ, Won YJ, Lee JY, Park EC, Lee JS. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008. Cancer Res Treat. 2011; 43:1–11.

3. Korea Cancer Registry. 2009 Korea cancer registry statistics. accessed on 8 October 2012. Available at http://ncc.re.kr/manage/manage03_033_list.jsp.

4. Kim J, Hahm MI, Park EC, Park JH, Park JH, Kim SE, Kim SG. Economic burden of cancer in South Korea for the year 2005. J Prev Med Public Health. 2009; 42:190–198.

5. Murray CJ. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ. 1994; 72:429–445.

6. Murray CJ, Kreuser J, Whang W. Cost-effectiveness analysis and policy choices: investing in health systems. Bull World Health Organ. 1994; 72:663–674.

7. Mathers C, Vos T, Stevenson C. The burden of disease and injury in Australia: AIHW cat. no. PHE 17. Canberra: Australian Institute of Health and Welfare;1999.

8. Yoon SJ, Lee H, Shin Y, Kim YI, Kim CY, Chang H. Estimation of the burden of major cancers in Korea. J Korean Med Sci. 2002; 17:604–610.

9. The World Bank. World development report 1993. New York: Oxford University Press;1993.

10. Murray CJ, Lopez AD, Jamison DT. The global burden of disease in 1990: summary results, sensitivity analysis and future directions. Bull World Health Organ. 1994; 72:495–509.

11. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997; 349:1498–1504.

12. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006; 3:e442.

13. Jayatilleke N, Pashayan N, Powles JW. Burden of disease due to cancer in England and Wales. J Public Health (Oxf). 2012; 34:287–295.

14. Fernández de Larrea-Baz N, Alvarez-Martín E, Morant-Ginestar C, Gènova-Maleras R, Gil A, Pérez-Gómez B, López-Abente G. Burden of disease due to cancer in Spain. BMC Public Health. 2009; 9:42.

15. Park JH, Yoon SJ, Lee HY, Cho HS, Lee JY, Eun SJ, Park JH, Kim Y, Kim YI, Shin YS. Estimating the burden of psychiatric disorder in Korea. J Prev Med Public Health. 2006; 39:39–45.

16. Stouthard MEA, Essink-Bot ML, Bonsel GJ, Barendregt JJ, Kramers PGN, van de Water HPA, Gunning-Schepers LJ, van der Maas PJ. Disability weights for diseases in the Netherlands. Rotterdam: Department of Health, Erasmus University;1997.

17. World Health Organization. National burden of disease studies: a practical guide, edition 2.0. Geneva: World Health Organization;2001.

18. Lee JK, Yoon SJ, Do YK, Kwon YH, Kim CY, Park K, Kim YI, Shin YS. Disability weights for diseases in Korea. Korean J Prev Med. 2003; 36:163–170.

19. Do YK, Yoon SJ, Lee JK, Kwon YH, Lee SI, Kim C, Park K, Kim YI, Shin Y. Disability weights for the Korean burden of disease study: focused on comparison with disability weights in the Australian burden of disease study. Korean J Prev Med. 2004; 37:59–71.

20. Essink-Bot ML, Pereira J, Packer C, Schwarzinger M, Burstrom K. Cross-national comparability of burden of disease estimates: the European Disability Weights Project. Bull World Health Organ. 2002; 80:644–652.

21. Statistics Korea. Statistics on acceptance rates of national early-screening programs for cancer. accessed on 8 October 2012. Available at http://www.index.go.kr/egams/stts/jsp/potal/stts/PO_STTS_IdxMain.jsp?idx_cd=1440&bbs=INDX_001&clas_div=A.

22. Yeoh KG. How do we improve outcomes for gastric cancer? J Gastroenterol Hepatol. 2007; 22:970–972.

23. Kim ER, Bae SY, Lee KH, Lee KT, Son HJ, Rhee JC, Lee JK. Is health screening beneficial for early detection and prognostic improvement in pancreatic cancer? Gut Liver. 2011; 5:194–199.

24. Jeong GT, Ha BC. 2020 vision and strategy of health service industry in Korea: Korea Institute for Industrial Economics and Trade Policy report 2007-66. Seoul: Korea Institute for Industrial Economics and Trade Policy;2007.

25. National Cancer Center. National cancer control programs. accessed on 8 October 2012. Available at http://ncc.re.kr/english/programs/intro.jsp.

26. National Health Insurance Corporation. 2010 medical utilization statistics by region. accessed on 8 October 2012. Available at http://www.nhic.or.kr/portal/site/main/menuitem.39c0ace4c6056b404bf15151062310a0.

27. Park YH. Utilization patterns of other region inpatients in general hospitals located in Seoul area. accessed on 8 October 2012. Korean J Health Serv Manag Available at http://www.hospitalreport.kr/frame1.htm.

28. Moon YO, Park EC, Shin HR, Won YJ, Jung KW, Lee JH, Hwang SY, Kong HJ, Hwang SS, Lee JK, et al. Regional variation in accessing regional hospitals for cancer patients. Korean J Epidemiol. 2006; 28:152–161.

29. Froberg DG, Kane RL. Methodology for measuring health-state preferences-III: population and context effects. J Clin Epidemiol. 1989; 42:585–592.

30. Essink-Bot ML, Bonsel GJ. How to derive disability weights?. In : Murray CJL, Salomon JA, Mathers CD, Lopez AD, editors. Summary measures of population health: concepts, ethics, measurement and applications. Geneva: World Health Organization;2002.

31. Mathematics in Education and Industry. Spearman's rank correlation: MEI paper series. accessed on 8 October 2012. Available at http://www.mei.org.uk/files/pdf/Spearmanrcc.pdf.

32. Mayo Clinic. Cancer patients' quality of life directly relates to their survival. accessed on 8 October 2012. Available at from http://www.sciencedaily.com/releases/2008/05/080516094428.htm.

33. Ustün TB, Rehm J, Chatterji S, Saxena S, Trotter R, Room R, Bickenbach J. Multiple-informant ranking of the disabling effects of different health conditions in 14 countries: WHO/NIH Joint Project CAR Study Group. Lancet. 1999; 354:111–115.

34. Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J. Harrison's principles of internal medicine: malignancies of lymphoid cells. 18th ed. New York: Mc-Graw Hill Professional;accessed on 8 October 2012. Available at http://accessmedicine.com/resourceTOC.aspx?resourceID=4.

35. National Cancer Institute. Cancer topics: types of leukemia. accessed on 8 October 2012. Available at http://www.cancer.gov/cancertopics/wyntk/leukemia/page3.